.st0{fill:#FFFFFF;} .st1{fill:#CE0E2D;} .st2{fill:#231F20;} BIMEDA USA ABOUT PRODUCTS NEWS CAREERS CONTACT Bimeda News Bimeda Acquires AquaTactics Fish Health Bimeda is pleased to announce the acquisition of AquaTactics Fish Health ("AquaTactics"), based in Seattle, Washington. The company was founded in 2009 by Dr Tom Goodrich and Hugh Mitchell DVM. The company provides fish health services and develops, ... Wednesday, 26 May 2021 Technical Services Veterinarian, Dr. Chris Thomsen Bimeda is pleased to announce the addition of Dr. Chris Thomsen in the role of field based Technical Services Veterinarian, with a focus on beef cattle. Dr. Thomsen will also assist with Equine Techni... Friday, 05 November 2021 Public Safety Message Dear Customers, Distributors and Retailers, Bimeda received communication from the Food and Drug Administration's (FDA) Center for Veterinary Medicine (CVM) regarding continued concerns that people ar... Tuesday, 07 September 2021 Bimeda Welcomes Ben Siegfried Bimeda® is pleased to announce the appointment of Ben Siegfried as a Regional Strategic Sales Manager for the states of Nebraska and Iowa. Ben will be an integral part of the livestock sales team and ... Tuesday, 20 April 2021 Bimeda Welcomes Tim Blackstone Bimeda® is pleased to announce Tim Blackstone in the new role of Territory Sales Manager for the Upper Midwest/Plains including the states of North Dakota, South Dakota, Minnesota, and Wisconsin. Tim ... Tuesday, 20 April 2021 Bimeda Launches Macrosyn™ (tulathromycin injection) 100 mg/mL, becoming the first available and launched FDA-approved brand alternative Draxxin® in the US. Bimeda is pleased to announce the launch of Macrosyn (tulathromycin injection) 100mg/mL. Macrosyn is a ready-to-use injectable solution containing 100 mg of tulathromycin/mL, a broad spectrum, fast-ac... Friday, 19 February 2021 CONGRATULATIONS We would like to congratulate Stephanie Batliner, Director of Regulatory Affairs of North America, on her election to the role of Chair of GADA (Generic Animal Drug Alliance). We would like to c... Thursday, 17 December 2020 Bimeda Announces Expanded Marketing Efforts and Packaging Options For Confidence EQ After Product Achieves Notable Marketplace Success Following consistent growth and popularity of Bimeda® lnc.'s Confidence EQ®, the parent company announced plans to expand marketing efforts and packaging options today for the equine appeasing ph... Thursday, 08 October 2020 Bimeda Biologicals Introduces Dr Paul Lawrence, Research and Development Director We welcome Dr. Paul Lawrence as the Research and Development Director for Bimeda Biologicals. Dr. Lawrence will manage and provide strategic direction in the development of USDA approved products and ... Monday, 05 October 2020 Bimeda Welcomes David Christian Bimeda® is pleased to announce the appointment of David Christian as a Strategic Sales Account Manager for the Livestock Southern Region (Texas, Oklahoma and Eastern New Mexico). David will work as pa... Monday, 31 August 2020 Bimeda Announces ‘Bimeda Biologicals Inc’ as Name for Acquired Vaccine Company Bimeda Inc. is pleased to announce the formal renaming of acquired vaccine production, research and diagnostic company, Texas Vet Lab, Inc., as Bimeda Biologicals Inc. Both Texas Vet Lab, Inc. (TVL) a... Thursday, 28 May 2020 Previous Next 1 2 3 Bimeda USA About Products News Careers Contact Bimeda Global Careers at Bimeda About Bimeda Global Regional Websites Global Facilities Privacy Policy Bimeda® US - Head Office One Tower Lane, Suite 2250, Oakbrook Terrace, IL 60181 1‑888‑524‑6332 1-630‑928‑0361 © 2021 Bimeda, Inc. All rights reserved. Facebook Twitter Linkedin Designed by ProbaseWeb